Adverse Reactions and Interactions with H2-Receptor Antagonists
The DOI matches its Crossref record; 324 of the 326 references it cites were found in a registry or an index.
Abstract
Histamine H2-receptor antagonists have been used in the treatment of gastrointestinal diseases for more than a decade and during this period have become one of the most commonly prescribed groups of drugs in the world. The deserved popularity of the H2-receptor antagonists reflects, in part, their therapeutic efficacy, which has revolutionised the treatment of peptic ulcer disease. An equally, or more, important reason for the widespread use of H2-receptor antagonists is their remarkably low toxicity. We have attempted, in this review, to present a detailed account of the minor and more serious adverse reactions, while emphasising the low incidence of the former and the rarity of the latter. The toxicology of the H2-receptor antagonists is discussed under two main headings: adverse effects; and drug interactions. The latter category is potentially the more significant, since the frequent use of therapy with multiple drugs may give rise to drug interactions, some of which are serious and may even be lethal. These drug interactions occur especially in the gastrointestinal tract, the liver and the kidneys. Thus, the absorption of other drugs may be altered because the H2-receptor antagonists inhibit gastric secretion--an effect illustrated by ketoconazole, the absorption of which is reduced when given in combination with cimetidine. Very important drug interactions are caused by inhibition of the hepatic microsomal enzyme cytochrome P450 by some of the H2-receptor antagonists. T…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are drug-drug interactions that can occur with H2 antihistamines through decreased gastric acidity and inhibition of P450.1192”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1192]
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
The American Journal of Physiology
(1899) · The American Naturalist · doi:10.1086/277182 · Cited by 5,654
Drug Metabolism and Disposition
(2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12259_4 · Cited by 2,515
(2012) · Hepatogastroenterology · doi:10.5754/hge12183 · Cited by 1,625
NEW YORK STATE JOURNAL OF MEDICINE.
(1901) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1901.02470020041007 · Cited by 1,472
American Journal of Hospital Pharmacy
Francke, D. E. (1958) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/15.1.37 · Cited by 932
(2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00347-3 · Cited by 705
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)01892-6 · Cited by 649
Lebrec, D., Poynard, T., Hillon, P., & Benhamou, J.-P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112033052302 · Cited by 517
Clinical pharmacology and therapeutics
Fenn, G. C. (1990) · Postgraduate Medical Journal · doi:10.1136/pgmj.66.778.686 · Cited by 479
Research works printed but not linked: 34
- Aymard B, Aymard JP, Netter P, Legras B, Streiff F. Cytopenies sanguines associees a la prise de cimetidine. Therapie 39: 545–553, 1984
- Belaiche J, Zitoun J, Marquet J, Nurit Y, Yvart J. Effet de la ranitidine sur la secretion de facteur intrinseque gastrique et sur l’absorption de la vitamine B12. Gastroenterologie Clinique et Biologique 7: 381–384, 1983
- Bertaccini C, Coruzzi G. H2 receptor antagonists: side-effects and adverse effects. Italian Journal of Gastroenterology 16: 119–124, 1984
- Bertaccini G, Licchin L, Bonoldi C, Felder H, Debrilla G. Absence of.cholinergic-like activity of ranitidine on human salivary and lacrimal secretions. Italian Journal of Gastroenterology 13: 253–254, 1981
- Bianchi Porro G, Cheli R. Gynaecomastia and ranitidine. Italian Journal of Gastroenterology 16: 56, 1984
- Bianchi Porro G, Petrillo M, Recchia G. The safety of ranitidine: 1981–83 post-marketing surveillance experience in Italy. Clinical Trials Journal 22: 441–447, 1985a
- Braito E, Oberlechner R, Camberlato R, Amplatz S, Dobrilla G. Heart rate and blood pressure in non-cardiopathic volunteers receiving acute intravenous loads of H2-antagonists. Trial based on Holter-Edwards dynamic electrocardiography. Italian Journal of Gastroenterology 17: 176, 1985
- Buchanan KD, Spencer A, Ardill J, Kennedy TL. Hypergastrinaemia due to cimetidine. Gut 19: A437, 1978
- Cavallini G, Angelini G, Vaona B, Bovo P, Rosa B, et al. Ranitidine and Candida albicans. Italian Journal of Gastroenterology 15: 189, 1983
- Dabadie H, Lamouliatte H, Quinton A, Geniaux M. Syndrome de Lyell induit par la cimetidine. Gastroenterologie Clinique et Biologique 7: 425–426, 1983
- Dobrilla G, Coruzzi G, Bertaccini G, Carvallini G. Extragastric effect of ranitidine. Italian Journal of Gastroenterology 14: 55–56, 1982
- Dorr RT. Effects of H2 antagonists on highly-metabolized anti-cancer drugs. Gastroenterology 88: 1368, 1985
- Enzmann GD, Leonard JM, Paulsen CA, Rogers J. Effect of cimetidine on reproductive function in men. Clinical Research 29: 26A, 1981
- Hadas N, Wapnick S, Grosberg SJ, Sugaar S. Cimetidine induced mortality in experimental pancreatitis. Gastroenterology 76: 1148, 1979
- Hagenmüller F, Usadel KH, Schwedes U, Zeitler-Abu-Ishira A, Classen M. Ranitidin und Cimetidin: Untersuchungen Zur Gastralen Sekretionshemmung und Antiandrogenität. Innere Medizin 9: 347–352, 1982
- Hansen WE, Nehammer K. Inhibition of cholinesterases by oxmetidine. Gastroenterology 86: 1107, 1984
- Hayakawa A, Che K, Miyoshi A, Harawara S, Miwa T, et al. Properties of famotidine in relation to safety. Italian Journal of Gastroenterology 16: 174–176, 1984
- Hine KR, Holmes GKT, Milnes JP, Phillips A, Poynter D, et al. Microscopic examination of gastric biopsies from patients treated with ranitidine. Gastroenterology 82: 1085, 1982
- Leslie GB, Walker TF. A toxicological profile of cimetidine. In Burland WL & Simkins MA (Eds). Cimetidine — proceedings of the second international symposium on histamine H2 receptor antagonists, pp. 24–33, Excerpta Medica, Amsterdam, 1977
- Lombardo L. Hyperprolactinaemia: ranitidine revisited adverse effect. Italian Journal of Gastroenterology 17: 160, 1985
- McGonigle RJS, Williams LC, Amphlett GE, England RJ, Parsons V. The pharmacokinetics of ranitidine in renal disease. In Misiewicz JJ & Wormsley KG (Eds). The clinical use of ranitidine, pp. 41–46, Medicine Publishing Foundation, Oxford 1982
- Mantero F. Ranitidine and gynaecomastia. Italian Journal of Gastroenterology 17: 114, 1985
- Mavier P, Preaux AM, Delchier JC, Beauchant M, Dhumeaux D. Comparaison des effets de la cimetidine et de la ranitidine in vivo et in vitro sur le systeme enzymtique microsomal hepatique chez le rat. Gastroenterologie Clinique et Biologique 7: 244–250, 1983
- Miyoshi A, Muto V, Mori H, Miwa T, Nakazawa S, et al. Famotidine: summary of overall safety from Japanese clinical studies. Italian Journal of Gastroenterology 16: 177–178, 1984
- Pallone F, Paoluzi P, Marcheggiano A, Ripoli F, Carratu R. Cimetidine and duodenal ulcer associated gastritis. Italian Journal of Gastroenterology 12: 210–211, 1980
- Paradelis AG, Triantaphyllidis CJ, Stavrakis AO, Crassaris LG. Interaction of aminoglycoside antibiotics with H2-receptor blocking agents at the neuromuscular junctions. Drugs in Experimental and Clinical Research 10: 807–811, 1984
- Pasquali R, Corinaldesi R, Patrono D, Capelli M, Stanghellini V, et al. Effect ot intravenous ranitidine on serum prolactin (PRL): evidence for a sex difference. Gastroenterology 84: 1271, 1983
- Peden NR, Wormsley KG. Alleged impotence with ranitidine. Lancet 2: 798, 1983
- Simon B, Müller P, Dammann HG. Safety profile of ranitidine. In Riley AJ & Salmon PR (Eds). Ranitidine, pp 181–189, Excerpta Medica, Amsterdam, 1982
- Simon B, Müller P, Dammann HG. Cimetidine, Ranitidin und Famotidin: eine vergleichende Wertung. Innere Medizin 11: 81–84, 1984
- Tomioka K, Yamada T, Tachikawa S. Effects of famotidine (YM11170), an H2-receptor antagonist, on in vivo immediate and delayed type hypersensitivity reactions and antibody formation. Drugs under Experimental and Clinical Research 9: 881–889, 1983
- Vickers MR, Arlington SA, Jones C, Martin D, Melvin MA. The role of histamine in immune responses. In Torsoli A, Lucchelli PE, Brimblecombe RW (Eds). Further experience with H2-receptor antagonists in peptic ulcer disease and progress in histamine research, pp 311–326, Excerpta Medica, Amsterdam, 1980
- Willing RL, Whitehead R, Oldmeadow M, Mackinnon M. Cimetidine and duodenitis — a placebo controlled double blinded study of the effect of cimetidine on the endoscopic and histological appearances of duodenitic mucosa. Gastroenterology 78: 1291, 1980
- Wilson JA, Craig IF. Cimetidine, ranitidine and HDL-cholesterol. Gastroenterology 88: 1632, 1985
Cited by
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options
Kuna, L., Jakab, J., Smolic, R., Raguz-Lucic, N., Vcev, A., & Smolic, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020179 · Cited by 349
Lancaster-Smith, M., Jaderberg, M. E., & Jackson, D. A. (1991) · Gut · doi:10.1136/gut.32.3.252 · Cited by 144
Pharmacokinetic Drug Interactions with Antimicrobial Agents
Gillum, J. G., Israel, D. S., & Polk, R. E. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199325060-00005 · Cited by 143
Vial, T., Goubier, C., Bergeret, A., Cabrera, F., Evreux, J. C., & Descotes, J. (1991) · Drug Safety · doi:10.2165/00002018-199106020-00002 · Cited by 66
Overuse of stress ulcer prophylaxis in the critical care setting and beyond
Farrell, C., Mercogliano, G., & Kuntz, C. L. (2009) · Journal of Critical Care · doi:10.1016/j.jcrc.2009.05.014 · Cited by 66
Review article: maintenance treatment with H2‐receptor antagonists for peptic ulcer disease
Penston, J. G., & Wormsley, K. G. (1992) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1992.tb00541.x · Cited by 58
Self-citationHe, J.-X., Akao, T., Nishino, T., & Tani, T. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.1395 · Cited by 53
Tirmizi, S. A., Wattoo, F. H., Wattoo, M. H. S., Sarwar, S., Memon, A. N., & Ghanghro, A. B. (2010) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2010.09.009 · Cited by 50
Greaves, P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-444-53856-7.00011-7 · Cited by 50
Choi, Y. J., Kim, N., Lee, J. Y., Nam, R. H., Chang, H., Seo, J. H., Kang, K. K., Kim, H. J., Choi, Y. J., Lee, H. S., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3370-5 · Cited by 36
Acid-Suppressive Therapy and Risk of Infections: Pros and Cons
Fisher, L., & Fisher, A. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0519-y · Cited by 43
Variables Associated with Stress Ulcer Prophylaxis Misuse: A Retrospective Analysis
Issa, I. A., Soubra, O., Chmaisse, H. N., & Soubra, L. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2104-9 · Cited by 32
“H2RAs can lead to ailments such as confusion, delirium, hallucinations, slurred speech, and thrombocytopenia [8, 33, 34].”
BackgroundSafety of acid-suppressing drugs
Smallwood, R. A., Berlin, R. G., Castagnoli, N., Festen, H. P. M., Hawkey, C. J., Lam, S., Langman, M. J. S., Lundborg, P. G., & Parkinson, A. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02214872 · Cited by 31
Pancytopenia associated with 5-aminosalicylic acid use in a patient with Crohn's disease
Kotanagi, H., Ito, M., Koyama, K., & Chiba, M. (1998) · Journal of Gastroenterology · doi:10.1007/s005350050135 · Cited by 29
Burci, L. M., Pereira, I. T., da Silva, L. M., Rodrigues, R. V., Facundo, V. A., Militão, J. S. L. T., Santos, A. R. S., Marques, M. C. A., Baggio, C. H., & Werner, M. F. D. P. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.04.006 · Cited by 26
Andersen, M. T., & Schou, J. S. (1991) · Pharmacology & Toxicology · doi:10.1111/bcpt.1991.69.4.253 · Cited by 21
Effects of H2‐receptor antagonists on the central nervous system
Berlin, R. G. (1989) · Drug Development Research · doi:10.1002/ddr.430170202 · Cited by 20
Risk for Adverse Events among Patients Receiving Intravenous Histamine 2 -Receptor Antagonists
Hartzema, A. G., Porta, M. S., Tilson, H. H., Joseph, R. B., Segal, R., & Russell, W. L. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302701221 · Cited by 18
A Rational Approach to Anaesthetic Premedication
Alpert, C. C., Baker, J. D., & Cooke, J. E. (1989) · Drugs · doi:10.2165/00003495-198937020-00009 · Cited by 18
Clinical Aspects of Cardiovascular Effects of H2‐Receptor Antagonists
Hinrichsen, H. M., Halabi, A., & Kirch, W. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04998.x · Cited by 17
Safety Implications of the Over-the-Counter Availability of H2-Antagonists
Andersen, M. T., & Schou, J. S. (1993) · Drug Safety · doi:10.2165/00002018-199308030-00001 · Cited by 17
Wormsley, K. G. (1993) · Drugs · doi:10.2165/00003495-199346060-00004 · Cited by 16
Self-citationWerbel, T., & Cohen, P. R. (2018) · Cureus · doi:10.7759/cureus.2414 · Cited by 15
Allegri, G., Pellegrini, K., & Dobrilla, G. (1988) · Inflammation Research · doi:10.1007/bf02028277 · Cited by 15
Fatima, S. F., Ishtiaq, S., Lashkar, M. O., Youssef, F. S., Ashour, M. L., & Elhady, S. S. (2022) · Metabolites · doi:10.3390/metabo12080750 · Cited by 14
“Furthermore, H2 receptor antagonists may cause gynecomastia and impotence [11].”
BackgroundHaemodynamic effects of H2‐receptor antagonists
Hinrichsen, H. M., Halabi, A., & Kirch, W. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01929.x · Cited by 14
Brewer, L., & Williams, D. J. (2013) · Pharmaceutical Medicine · doi:10.1007/s40290-013-0008-4 · Cited by 14
“For example, proton pump inhibitors [16] or histamine H2 receptor antagonists [17] (that reduce gastrointestinal acidity) can influence the absorption of Table 1 Classification of interactions by severity [9]”
BackgroundAnaphylactic reaction to ranitidine (Zantac®)
Han, T. Y., Jang, W. S., Yu, M., Lee, H. K., Son, S., & Seo, S. J. (2011) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04834.x · Cited by 11
In vitro interactions of captopril with H2-receptor antagonists.
Sultana, N., Arayne, M. S., & Quraish, R. (2007) · PubMed · Cited by 11
The Safety Assessment of Over-The-Counter (OTC) Products
Schmid, B. E. (1995) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-79451-3_25 · Cited by 10
Comparative effects of H2‐receptor antagonists on subjective and objective assessments of sleep
Orr, W. C., DUKE, J. C., Imes, N. K., & Mellow, M. H. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00279.x · Cited by 10
Safety profile of long‐term H2‐antagonist therapy
Lewis, J. H. (1991) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1991.tb00748.x · Cited by 10
Ranitidine treatment inducing methemoglobinemia in male Wistar rats
Malfará, W. R., de Souza, A. M., & Queiróz, R. H. C. (2005) · Revista Brasileira De Ciencias Farmaceuticas · doi:10.1590/s1516-93322005000200013 · Cited by 8
Penston, J. G., Dixon, J. S., Selway, S. A. M., & Wormsley, K. G. (1990) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1990.tb00484.x · Cited by 8
Self-citationThe Use of Intravenous H2-Receptor Antagonists in A Tertiary Care Hospital
Dettmer, R. M., Riley, T. H., Byfield, F., & Green, P. H. R. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00669-3 · Cited by 7
Lucas, B. D., Williams, M. A., Mohiuddin, S. M., LaMadrid, L., Schroeder, L. J., & Hilleman, D. E. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03903.x · Cited by 6
The Introduction of H2-Receptor Antagonists to Scandinavia: Effects of Experts' Opinions
Molinder, H. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850170766 · Cited by 6
Histamine H2-Receptor Antagonists Versus Prostaglandins in the Treatment of Peptic Ulcer Disease
Penston, J. G., & Wormsley, K. G. (1989) · Drugs · doi:10.2165/00003495-198937040-00001 · Cited by 6
Self-citationHerbal Potentials for Treatment of Peptic Ulcers: A Review
Wakodkar, S. B., Shuddalwar, A., & Baheti, J. (2021) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2021.v68i02.019 · Cited by 5
Nutraceuticals in Gastrointestinal Disorders
Banerjee, A. A., & Giri, R. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00009-7 · Cited by 6
Nutraceuticals in gastrointestinal disorders
Gupta, R. C., Doss, R. B., Banerjee, A. A., Lall, R., Srivastava, A., & Sinha, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00010-0 · Cited by 5
Rhinitis and asthma due to ranitidine.
Martínez, A. J. C., Melgosa, A. C., Gonzalo, M. J. F., & Martín, C. (2006) · PubMed · Cited by 5
Keny, E. S., & Kale, P. P. (2022) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2021-0264 · Cited by 4
Treatment of Peptic Ulcer Disease in the Arthritic Patient
Nunes, D., Kennedy, N. P., & Weir, D. G. (1989) · Drugs · doi:10.2165/00003495-198938030-00006 · Cited by 3
The place of famotidine in anti‐ulcer therapy
MANN, S. G. (1987) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1987.tb00659.x · Cited by 3
Shankar Ganesh, M., Asifsha, D., & Venkateswaramurthy, N. (2024) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3243 · Cited by 2
Greaves, P. (2007) · Elsevier eBooks · doi:10.1016/b978-044452771-4/50012-2 · Cited by 2
Maintenance therapy for peptic ulcer disease
Wormsley, K. G. (1991) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1991.tb00747.x · Cited by 2
Self-citationIsaacs, M. J., & Tharp, M. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-61211-1.00032-2 · Cited by 2
Wormsley, K. G. (1988) · BMJ · doi:10.1136/bmj.297.6660.1392 · Cited by 2
Self-citationLangman, M. J. S. (1988) · Side effects of drugs annual · doi:10.1016/s0378-6080(88)80103-x · Cited by 2
Iwata, M., Nawata, S., Takahashi, Y., Yamanashi, K., Yoshihara, R., Sakai, K., 三尾, 良., & YAMAMOTO, K. (2003) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.29.593 · Cited by 1
Greaves, P. (2000) · Elsevier eBooks · doi:10.1016/b978-044450514-9/50010-3 · Cited by 1
Female breast engorgement on ranitidine--a case report.
Ray, S. (1989) · PubMed
Chapman, S. (1996) · Practice Nursing · doi:10.12968/pnur.1996.7.17.5121
Drug Information Analysis Service
Hart, L. L., & Middleton, R. K. (1988) · Annals of Pharmacotherapy · doi:10.1177/106002808802201212
(1990) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529009094503
The Review on Peptic Ulcer Disease
-, N. S. P., & -, P. B. M. (2022) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2022.v04i06.1044
Investigating the Progression of Lifestyle Changes in Peptic Ulcer
Ade, P. S., Apet, R. S., Mohite, S. A., Lomate, P. B., Chate, A. V., & Panchabhai, V. B. (2024) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2024.63776
Metadata
- Authors
- Pension, J., & Wormsley, K. G.
- Affiliations
- University of Dundee (GB)
- Venue
- Medical Toxicology
- Published
- 1986-06
- Volume
- 1
- Issue
- 3
- Pages
- 192-216
- ISSN
- 0112-5966 (ISSN-L)
- OpenAlex
- W2465608970
- Cited by
- 63
- References
- 326
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Medical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- H2 receptor antagonists, adverse drug reactions, drug interactions, cimetidine, ranitidine, ketoconazole, cytochrome P450 inhibition, drug metabolism, gastric acid secretion, drug absorption, renal tubular secretion, procainamide, quinidine, peptic ulcer, drug toxicity, gastrointestinal adverse effects, renal adverse effects
- MeSH terms
- Animals, Cardiovascular Diseases, Central Nervous System Diseases, Digestive System Diseases, Drug Interactions, Endocrine System Diseases, Hematologic Diseases, Histamine H2 Antagonists, Humans, Kidney Diseases, Skin Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.